Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesPaul W. Sperduto, Minesh P. Mehta, Amit Bhatt et al.|Journal of Clinical Oncology|2011Cited by 1.4k
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 PatientsPaul W. Sperduto, Minesh P. Mehta, Samuel T. Chao et al.|International Journal of Radiation Oncology*Biology*Physics|2009Cited by 984
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialPaul D. Brown, S. Pugh, Nadia N. Laack et al.|Neuro-Oncology|2013Cited by 942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al.|Journal of Clinical Oncology|2020Cited by 827
Estimating Survival in Patients With Lung Cancer and Brain MetastasesPaul W. Sperduto, Minesh P. Mehta, Jonathan T. Yang et al.|JAMA Oncology|2016Cited by 655